Sage Therapeutics, Inc. Variable Lease, Cost
Sage Therapeutics, Inc. reported Variable Lease, Cost of $1.45 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2025-02-11
- Sage Therapeutics, Inc. variable lease, cost for fiscal 2024 was $1.45M, a 25.70% decline from fiscal 2023.
- Sage Therapeutics, Inc. variable lease, cost for fiscal 2023 was $1.96M, a 6.01% increase from fiscal 2022.
- Sage Therapeutics, Inc. variable lease, cost for fiscal 2022 was $1.85M, a 15.38% increase from fiscal 2021.
- Sage Therapeutics, Inc. variable lease, cost for fiscal 2021 was $1.60M, a 29.98% decline from fiscal 2020.
| Period end | Variable Lease, Cost 12 month |
|---|---|
| 2024-12-31 | $1.45M 10-K · filed 2025-02-11 |
| 2023-12-31 | $1.96M 10-K · filed 2025-02-11 |
| 2022-12-31 | $1.85M 10-K · filed 2025-02-11 |
| 2021-12-31 | $1.60M 10-K · filed 2024-02-14 |
| 2020-12-31 | $2.29M 10-K · filed 2023-02-16 |
| 2019-12-31 | $2.67M 10-K · filed 2022-02-24 |